W. Lescaut

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Reid W. Merryman, Haesook T. Kim, Pier Luigi Zinzani et al. · Blood · 2017 · 236 citations · Full text

Medicine, Hematology, Immunology +16

Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity

S. Beauclair, Patricia Formento, Jean–Louis Fischel et al. · Annals of Oncology · 2007 · 119 citations · Full text

Medicine, Genetics, Oncology +12

Characterization of centromere alterations in liposarcomas

Nicolas Sirvent, Anne Forus, W. Lescaut et al. · Genes Chromosomes and Cancer · 2000 · 72 citations

Medicine, Oncology, Pathology +17

HER2 genetic polymorphism and pharmacodynamics of trastuzumab-based treatment in breast cancer patients

G. Milano, W. Lescaut, Jean–Louis Formento et al. · Journal of Clinical Oncology · 2005 · 18 citations

Medicine, Oncology, Pharmacology +14

Real-World Experience of Bevacizumab as First-Line Treatment for Ovarian Cancer: The GINECO ENCOURAGE Cohort of 468 French Patients

Dominique Berton, Anne Floquet, W. Lescaut et al. · Frontiers in Pharmacology · 2021 · 11 citations · Full text

Medicine, Gynecology, Oncology +14